FreeStyle Libre’s flash glucose monitoring system improves control in people with Type 1 diabetes during the first six months of use, says a nationwide audit.
Presented at the American Diabetes Association’s 79th Scientific Session, the first milestone results of 1,299 people with Type 1 diabetes from the Association of British Clinical Diabetologists (ABCD) audit compared the 12 months before starting FreeStyle Libre and the results of using ‘Flash’ after six months.
These results demonstrated essential benefits to people with diabetes, both in lowering glucose levels in those with high levels before use of the device and a reduction of hypoglycaemic episodes, ABCD said. The findings include:
- Significant improvement diabetes control, as measured by HbA1c particularly in those people with higher levels before use of FreeStyle Libre
- 79% reported that with the use of FreeStyle Libre they were able to reduce the proportion of time hypo, 31% able to reduce the rate/frequency of hypos, 39% had reduced nocturnal hypos
- A reduction in hospital admissions for hypos, hypers, and diabetic ketoacidosis (one-year follow-up data is needed to confirm these findings).
Read the full ABCD Audit.
